Our research shows the transformative effect that alemtuzumab can have for people with MS.
Patients who continue to show disease activity while on their initial therapy are especially difficult to treat.
Now, we have shown that alemtuzumab works where first-line drugs have already failed.
It not only reduces the chances of disability associated with MS but may even result in long-term clinical improvements.
More top news
Rain spreading eastwards throughout the day.
"His fiancee gave birth this morning, of all mornings! We were scared because we've got Glastonbury tonight", said co-singer Chloe Rhodes.
Festival-goers have been enjoying the second day of the Glastonbury festival.